Return
The role of PANoptosis regulatory networks in acute neurological injury
Z
C
W
Z
Y
王
Y
S
L
H
DOI:10.1016/j.nbd.2026.107566.png)
Abstract
En 中文
Secondary injury following acute neurological insults—including stroke, spinal cord injury(SCI), traumatic brain injury(TBI), and subarachnoid hemorrhage(SAH)—is a major contributor to neuronal death and neuroinflammation; however, the complex molecular mechanisms driving these pathological processes remain poorly understood. The limited efficacy of traditional apoptosis-targeted therapies highlights the need to investigate alternative regulated cell death pathways governed by diverse and intricate regulatory networks. PANoptosis, an emerging form of inflammatory programmed cell death initially proposed to describe the crosstalk among apoptosis, pyroptosis, and necroptosis, is regulated by dynamic molecular complexes, such as the PANoptosome, which orchestrate multiple cell death-associated pathways and contribute to neuronal loss and the amplification of inflammatory responses. This review provides a comprehensive overview of the molecular mechanisms of PANoptosis and its functional roles in acute neurological injury, with a particular emphasis on its pathological regulatory networks associated with ischemic stroke and spinal cord injury. Furthermore, we highlight emerging therapeutic strategies targeting PANoptosis. Recent evidence has identified key molecular mediators, including Z-DNA-binding Protein 1 (ZBP1), receptor-Interacting Protein Kinase 1 (RIPK1), and TGF-β-Activated Kinase 1 (TAK1), which regulate PANoptosome assembly and downstream effector pathways, highlighting their potential as promising therapeutic targets. Inhibition of PANoptosis has been shown to markedly alleviate blood-brain barrier (BBB) disruption and neurological deficits. Additionally, this review addresses the translational challenges and future research directions in targeting PANoptosis, providing a theoretical basis for the development of multi-targeted neuroprotective strategies.
Keywords:
PANoptosis
PANoptosome
Acute neurological injury
Programmed cell death
Multi-targeted therapy
Neuroinflammation
AAV
Adeno-Associated Virus
ACI
Acute Cerebral Infarction
ADCY
Adenylyl Cyclase
AIM2
Absent In Melanoma 2
ASC
Apoptosis-Associated Speck-Like Protein Containing a CARD
BAX
Bcl-2-Associated X Protein
BBB
Blood-Brain Barrier
CAD
caspase-Activated DNase
cGAMP
Cyclic GMP-AMP
cGAS-STING
Cyclic GMP-AMP Synthase – Stimulator of Interferon Genes
DAMPs
Damage-Associated Molecular Patterns
DED
Death Effector Domain
EH
Esculentoside H
EVs
Extracellular Vesicles
FADD
FAS-Associated Death Domain Protein
GSDMD
Gasdermin D
HMGB1
High Mobility Group Box 1
HSF1
Heat Shock Factor 1
IRF1
Interferon Regulatory Factor 1
IRF9
Interferon Regulatory Factor 9
IS
Ischemic Stroke
LAMP2
Lysosome-Associated Membrane Protein 2
Lgals3
Galectin-3 (official gene symbol)
MLKL
Mixed Lineage Kinase Domain-Like Protein
MMP-9
Matrix Metalloproteinase 9
MODS
Multiple Organ Dysfunction Syndrome
MOMP
Mitochondrial Outer Membrane Permeabilization
NAIP
NLR Apoptosis Inhibitory Protein
NBP
DL-3-n-Butylphthalide
NF-κB
Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells
NIHSS
National Institutes of Health Stroke Scale
NINJ1
Nerve Injury-Induced Protein 1
NLRC4
NLR Family CARD Domain Containing 4
NLRP12
NLR Family Pyrin Domain Containing 12
NLRP3
NOD-, LRR- and Pyrin Domain-Containing Protein 3
PAMPs
Pathogen-Associated Molecular Patterns
PCD
Programmed Cell Death
PGAM5
Phosphoglycerate Mutase Family Member 5
PRRs
Pattern Recognition Receptors
PSMD14
Proteasome 26S Subunit, Non-ATPase 14
PYD-CARD
Pyrin Domain – caspase Activation and Recruitment Domain
RCD
Regulated Cell Death
RHIM
RIP Homotypic Interaction Motif
RIPK1
Receptor-Interacting Protein Kinase 1
RIPK3
Receptor-Interacting Protein Kinase 3
ROS
Reactive Oxygen Species
SAH
Subarachnoid Hemorrhage
SCI
Spinal Cord Injury
STAT1
Signal Transducer and Activator of Transcription 1
TAK1
TGF-β-Activated Kinase 1
TBI
Traumatic Brain Injury
TUDCA
Tauroursodeoxycholic Acid
ZBP1
Z-DNA Binding Protein 1
Journal
IF:
5.6
Papers:
6.7K
Citations:
2.1W
